BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28660566)

  • 21. Familial Colorectal Cancer Type X.
    Zetner DB; Bisgaard ML
    Curr Genomics; 2017 Aug; 18(4):341-359. PubMed ID: 29081690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-occurrence of Lynch syndrome and juvenile polyposis syndrome confirmed by multigene panel testing.
    Silva-Smith R; Sussman DA
    Fam Cancer; 2018 Jan; 17(1):87-90. PubMed ID: 28600700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Broadening risk profile in familial colorectal cancer type X; increased risk for five cancer types in the national Danish cohort.
    Therkildsen C; Rasmussen M; Smith-Hansen L; Kallemose T; Lindberg LJ; Nilbert M
    BMC Cancer; 2020 Apr; 20(1):345. PubMed ID: 32321466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hereditary colorectal cancer diagnostics: morphological features of familial colorectal cancer type X versus Lynch syndrome.
    Klarskov L; Holck S; Bernstein I; Nilbert M
    J Clin Pathol; 2012 Apr; 65(4):352-6. PubMed ID: 22287689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New insights on familial colorectal cancer type X syndrome.
    Garcia FAO; de Andrade ES; de Campos Reis Galvão H; da Silva Sábato C; Campacci N; de Paula AE; Evangelista AF; Santana IVV; Melendez ME; Reis RM; Palmero EI
    Sci Rep; 2022 Feb; 12(1):2846. PubMed ID: 35181726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risks of Colorectal Cancer and Cancer-Related Mortality in Familial Colorectal Cancer Type X and Lynch Syndrome Families.
    Choi YH; Lakhal-Chaieb L; Kröl A; Yu B; Buchanan D; Ahnen D; Le Marchand L; Newcomb PA; Win AK; Jenkins M; Lindor NM; Briollais L
    J Natl Cancer Inst; 2019 Jul; 111(7):675-683. PubMed ID: 30380125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BRCA2 gene: a candidate for clinical testing in familial colorectal cancer type X.
    Garre P; Martín L; Sanz J; Romero A; Tosar A; Bando I; Llovet P; Diaque P; García-Paredes B; Díaz-Rubio E; de la Hoya M; Caldés T
    Clin Genet; 2015 Jun; 87(6):582-7. PubMed ID: 24814045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a population-based approach to familial colorectal cancer.
    Parfrey PS; Dicks E; Parfrey O; McNicholas PJ; Noseworthy H; Woods MO; Negriin C; Green J
    Clin Genet; 2017 May; 91(5):672-682. PubMed ID: 27696385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.
    Aaltonen LA; Salovaara R; Kristo P; Canzian F; Hemminki A; Peltomäki P; Chadwick RB; Kääriäinen H; Eskelinen M; Järvinen H; Mecklin JP; de la Chapelle A
    N Engl J Med; 1998 May; 338(21):1481-7. PubMed ID: 9593786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.
    Loughrey MB; Waring PM; Tan A; Trivett M; Kovalenko S; Beshay V; Young MA; McArthur G; Boussioutas A; Dobrovic A
    Fam Cancer; 2007; 6(3):301-10. PubMed ID: 17453358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
    Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
    J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study.
    Percesepe A; Borghi F; Menigatti M; Losi L; Foroni M; Di Gregorio C; Rossi G; Pedroni M; Sala E; Vaccina F; Roncucci L; Benatti P; Viel A; Genuardi M; Marra G; Kristo P; Peltomäki P; Ponz de Leon M
    J Clin Oncol; 2001 Oct; 19(19):3944-50. PubMed ID: 11579115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
    Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
    J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile polyposis.
    van Hattem WA; Brosens LA; de Leng WW; Morsink FH; Lens S; Carvalho R; Giardiello FM; Offerhaus GJ
    Gut; 2008 May; 57(5):623-7. PubMed ID: 18178612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A family with juvenile polyposis linked to the BMPR1A locus: cryptic mutation or closely linked gene?
    Chow E; Lipton L; Carvajal-Carmona LG; Arthur G; Bhathal P; Kaur G; Jaeger E; Woodford-Richens K; Howarth K; Tomlinson I; Macrae F
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2292-7. PubMed ID: 17573831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hereditary predisposition of colorectal cancer and prevalence of hereditary nonpolyposis colorectal cancer in general population of colorectal cancer patients in China].
    Zhang YZ; Sheng JQ; Li SR; Wu ZT
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2995-3000. PubMed ID: 16324388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
    Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
    Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.
    Lindor NM; Rabe K; Petersen GM; Haile R; Casey G; Baron J; Gallinger S; Bapat B; Aronson M; Hopper J; Jass J; LeMarchand L; Grove J; Potter J; Newcomb P; Terdiman JP; Conrad P; Moslein G; Goldberg R; Ziogas A; Anton-Culver H; de Andrade M; Siegmund K; Thibodeau SN; Boardman LA; Seminara D
    JAMA; 2005 Apr; 293(16):1979-85. PubMed ID: 15855431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison Between Familial Colorectal Cancer Type X and Lynch Syndrome: Molecular, Clinical, and Pathological Characteristics and Pedigrees.
    Xu Y; Li C; Zhang Y; Guo T; Zhu C; Xu Y; Liu F
    Front Oncol; 2020; 10():1603. PubMed ID: 32984025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.